Intrauterine therapy for fetal supraventricular tachycardia in a twin pregnancy

Journal of Obstetrics and Gynaecology Research

Volumn 31, Issue 2, 2005, Pages 94-97

  Tanawattanacharoen, Somchai ^a   Uerpairojkit, Boonchai ^a   Prechawat, Somchai ^a   Manotaya, Saknan ^a   Charoenvidhya, Dhiraphongs ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Anti arrhythmic drug; Digoxin; Hydrops fetalis; Supraventricular tachycardia; Twin pregnancy

Indexed keywords

ANTIARRHYTHMIC AGENT; DIGOXIN; STEROID;

ARTICLE; CASE REPORT; CESAREAN SECTION; DIGOXIN BLOOD LEVEL; ELECTROCARDIOGRAM; FETUS; FETUS DISEASE; FETUS HEART RATE; FETUS HYDROPS; FETUS LUNG MATURATION; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; MATERNAL BLOOD; SIDE EFFECT; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME; TWIN PREGNANCY;

ADULT; CESAREAN SECTION; DIGOXIN; DISEASES IN TWINS; FATAL OUTCOME; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; HYDROPS FETALIS; MALE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, MULTIPLE; TACHYCARDIA, SUPRAVENTRICULAR; ULTRASONOGRAPHY, PRENATAL;

EID: 17644390638     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2005.00252.x     Document Type: Article

References (11)

1. Reed KL. Fetal arrhythmias: Etiology, diagnosis, pathophysiology, and treatment. Semin Perinatol 1989; 13: 294-304.
2. Gembruch U, Krapp M, Baumann P. Changes of venous blood flow velocity waveforms in fetuses with supraventricular tachycardia. Ultrasound Obstet Gynecol 1995; 5: 394-399.
3. Kleinman CS, Copel JA, Weinstein EM, Santulli TV, Hobbins JC. In utero diagnosis, and treatment of fetal supraventricular tachycardia. Semin Perinatol 1985; 9: 113-119.
4. Simpson JM, Sharland GK. Fetal tachycardias: Management and outcome of 127 consecutive cases. Heart 1998; 79: 576-581.
5. Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002; 19: 158-164.
6. Echr DS, Liebson PR, Mitchell LB et al. Mortality and morbidity in patients receiving encainide and flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324: 781-788.
7. Kleinman CS, Nehgme R, Copel JA. Fetal cardiac arrhythmias: Diagnosis and therapy. In: Creasy RK, Resnik R (eds). Maternal-Fetal Medicine, 4th edn. Philadelphia: W.B. Saunders, 1999; 301-318.
8. Simpson LL, Marx GR, D'Alton MA. Supraventricular tachycardia in the fetus: Conservative management in the absence of hemodynamic compromise. J Ultrasound Med 1997; 16: 459-464.
9. Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander NS, Wladimiroff JW, Hess J. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Prenat Diagn 1995; 15: 1297-1302.
10. Edwards A, Peek M, Curren J. Transplacental flecainide therapy for fetal supraventricular tachycardia in twin pregnancy. Aust NZ J Obstet Gynaecol 1999; 39: 110-112.
11. Jones LM, Garmel SH. Successful digoxin therapy of fetal supraventricular tachycardia in a triplet pregnancy. Obstet Gynecol 2001; 98: 921-923.